Search Results

Filter
  • 1-10 of  4,571 results for ""Gout Suppressants""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of febuxostat in Japanese paediatric patients with hyperuricaemia including gout: Phase 2, single arm, open‒label, multicentre studies.

  • Authors : Ito S; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Kanagawa, Japan.; Morita Y

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Febuxostat*/Febuxostat*/Febuxostat*/adverse effects ; Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/drug therapy

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Dec 25; Vol. 35 (1), pp. 194-202.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction.

  • Authors : Iwama R; Translational Science Research Department, Teijin Institute for Bio-medical Research, Teijin Pharma Limited, Tokyo, Japan.; Nishida K

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/pharmacokinetics ; Febuxostat*/Febuxostat*/Febuxostat*/administration & dosage ; Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Dec; Vol. 12 (6), pp. e70032.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

Record details

×
Academic Journal

Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial.

  • Authors : Helget LN; Veterans Affairs Nebraska-Western Iowa Health Care System, Omaha, Nebraska; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address: .

Subjects: Febuxostat*/Febuxostat*/Febuxostat*/therapeutic use ; Febuxostat*/Febuxostat*/Febuxostat*/adverse effects ; Gout*/Gout*/Gout*/drug therapy

  • Source: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2024 Nov; Vol. 84 (5), pp. 538-545. Date of Electronic Publication: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An update on the pharmacotherapy of gout.

  • Authors : Yuan JSJ; Department of Rheumatology, Royal Free London NHS Foundation Trust, London, UK.; Department of Medicine, Barnet Hospital, London, UK.

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout Suppressants*/Gout Suppressants*/Gout Suppressants*/therapeutic use ; Uric Acid*/Uric Acid*/Uric Acid*/blood

  • Source: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2025 Jan; Vol. 26 (1), pp. 101-109. Date of Electronic Publication: 2024 Dec 18.Publisher: Informa Healthcare Country of Publication: England NLM ID: 100897346 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Knowledge of and Stated Adherence to the 2020 American College of Rheumatology Guideline for Gout Management: Results of a Survey of US Rheumatologists.

  • Authors : Schlesinger N; N. Schlesinger, MD, Division of the Rheumatology, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah; .

Subjects: Gout*/Gout*/Gout*/drug therapy ; Guideline Adherence*/Guideline Adherence*/Guideline Adherence*/statistics & numerical data ; Rheumatology*/Rheumatology*/Rheumatology*/standards

  • Source: The Journal of rheumatology [J Rheumatol] 2025 Jan 01; Vol. 52 (1), pp. 77-86. Date of Electronic Publication: 2025 Jan 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Effect of urate-lowering therapy on all-cause and CVD-specific mortality in gout and hyperuricemia: a meta-analysis.

  • Authors : Lee YH; Department of Rheumatology, Korea University Anam Hospital, Korea University College of Medicine, 73, Goryeodae-ro, Seongbuk-gu, 02841, Seoul, Korea (Republic of). .; Song GG

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/mortality ; Gout*/Gout*/Gout*/mortality ; Gout*/Gout*/Gout*/drug therapy

  • Source: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Dec; Vol. 83 (Suppl 3), pp. 338-344. Date of Electronic Publication: 2024 Dec 05.Publisher: Springer Country of Publication: Germany NLM ID: 0414162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-1250

Record details

×
Academic Journal

Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis.

  • Authors : Jamil Y; Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Alameddine D

Subjects: Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/drug therapy ; Hyperuricemia*/Hyperuricemia*/Hyperuricemia*/complications ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control

  • Source: Current cardiology reports [Curr Cardiol Rep] 2024 Dec; Vol. 26 (12), pp. 1427-1437. Date of Electronic Publication: 2024 Oct 01.Publisher: Current Science Country of Publication: United States NLM ID: 100888969 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Baseline Dual-Energy Computed Tomography Urate Volume Predicts Fulfillment of Gout Remission After Two Years of Urate-Lowering Therapy.

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/diagnostic imaging ; Gout*/Gout*/Gout*/blood

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Dec; Vol. 76 (12), pp. 1657-1665. Date of Electronic Publication: 2024 Aug 29.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate-Lowering Therapy During Remission: A Mixed-Methods Study.

  • Authors : Peeters IR; Sint Maartenskliniek, Ubbergen, the Netherlands and Radboud University, Nijmegen, the Netherlands.; Veenstra F

Subjects: Gout*/Gout*/Gout*/drug therapy ; Gout*/Gout*/Gout*/blood ; Gout Suppressants*/Gout Suppressants*/Gout Suppressants*/therapeutic use

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Nov; Vol. 76 (11), pp. 1574-1583. Date of Electronic Publication: 2024 Jul 23.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Association of rare and common genetic variants in MOCOS with inadequate response to allopurinol.

  • Authors : Fanning NC; Department of Medicine, University of Otago, Christchurch, Aotearoa, New Zealand.; Cadzow M

Subjects: Allopurinol*/Allopurinol*/Allopurinol*/therapeutic use ; Gout*/Gout*/Gout*/genetics ; Gout*/Gout*/Gout*/drug therapy

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Nov 01; Vol. 63 (11), pp. 3025-3032.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  4,571 results for ""Gout Suppressants""